Form 4: Procept BioRobotics Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Hisham Shiblaq, EVP and Chief Commercial Officer of Procept BioRobotics, sold 244 shares of common stock on March 18, 2024, to cover tax withholding obligations related to vesting Restricted Stock Units.
Summary
- On March 18, 2024, Hisham Shiblaq, the EVP and Chief Commercial Officer of Procept BioRobotics Corp, sold 244 shares of common stock.
- The sale was executed at a weighted average price of $48.83 per share.
- The transaction was to cover tax withholding obligations related to the vesting of Restricted Stock Units granted on March 31, 2022.
- Following the transaction, Shiblaq directly owns 55,860 shares of Procept BioRobotics Corp.
Sentiment
Score: 5
Explanation: This is a neutral event, reflecting a standard transaction for covering tax obligations related to stock-based compensation.
Industry Context
This is a routine transaction related to executive compensation and tax obligations, common in publicly traded companies.
Stakeholder Impact
- The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to be significant given the small number of shares involved.
Key Dates
| Date | Description |
|---|---|
| 03/31/2022 | Date of grant for the Restricted Stock Units related to the tax obligation. |
| 03/18/2024 | Date of the stock sale transaction. |
| 03/20/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.